What is the preferred nebulizer treatment for shortness of breath (SOB) due to Coronavirus disease 2019 (COVID-19)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preferred Nebulizer Treatment for Shortness of Breath Due to COVID-19

For patients with shortness of breath due to COVID-19, metered-dose inhalers (MDIs) should be used instead of nebulizers whenever possible to reduce viral transmission risk, but when nebulization is necessary, a vibrating mesh nebulizer (VMN) is preferred, especially in ventilated patients, to minimize aerosol dispersion. 1

First-Line Approach

Avoid Nebulization When Possible

  • Nebulization is generally discouraged in COVID-19 patients due to the risk of viral aerosolization 1
  • Use MDIs with spacers as the first-line delivery method for bronchodilators when possible 1

When Nebulization is Necessary

  1. Preferred Device Selection:

    • Vibrating mesh nebulizers (VMNs) are preferred over jet nebulizers 1, 2
    • VMNs produce less fugitive aerosol and can be used in closed ventilator circuits without breaking the circuit 1
  2. Medication Selection:

    • Bronchodilators (albuterol/salbutamol) remain the primary treatment for bronchospasm 2, 3
    • Avoid nebulized corticosteroids in mild COVID-19 cases 4
    • For severe cases requiring oxygen support, consider:
      • Nebulized budesonide (1mg twice daily) for patients not requiring mechanical ventilation 2
      • Dornase alfa with albuterol may be beneficial for intubated patients with thick secretions 3

Safety Precautions During Nebulization

For Non-Intubated Patients:

  • Place a surgical mask over the patient's face during nebulization 1
  • Use a transnasal approach for bronchoscopy if needed 1
  • Avoid high-flow nasal oxygen therapy during nebulization 1
  • Consider using a transparent protective box to contain droplet particles 1
  • Ensure proper room ventilation and healthcare worker PPE 1

For Intubated Patients:

  • Use a closed circuit with viral filters in both arms 1
  • Maintain cuff pressure between 25-30 cmH2O on endotracheal tubes 1
  • Clamp the ventilation circuit just before introduction and withdrawal of any device 1
  • Use VMNs that don't require breaking the ventilator circuit 1

Special Considerations

Severe COVID-19 Cases:

  • For patients requiring oxygen or ventilatory support, systemic corticosteroids are recommended rather than nebulized ones 4
  • Consider methylprednisolone (1 mg/kg IV) for severe cases, which has shown improved outcomes including reduced mortality compared to other corticosteroid regimens 2

Patients with Underlying Respiratory Conditions:

  • For COPD patients with COVID-19, optimize dual bronchodilators early 5
  • Use caution with inhaled corticosteroids in patients with recent pneumonia 5
  • Monitor for interstitial lung disease that may worsen post-COVID infection 5

Common Pitfalls to Avoid

  1. Transmission Risk:

    • Avoid breaking ventilator circuits unnecessarily 1
    • Don't use nebulizers in shared spaces without proper precautions 1
  2. Medication Errors:

    • Avoid premature use of corticosteroids in mild disease 4
    • Don't withhold bronchodilators when clinically indicated due to fear of aerosolization 1
  3. Ventilation Management:

    • Avoid high airway pressures during nebulization 1
    • Don't use high-flow nasal oxygen during nebulization procedures 1

By following these guidelines, clinicians can effectively manage shortness of breath in COVID-19 patients while minimizing transmission risks to healthcare workers and other patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

COVID-19 Pharyngitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Managing Post COVID-19 Patient with Breathlessness.

Case reports in medicine, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.